Novartis and Roche ordered to pay €30.9 million cartel fine
The Turkish Competition Authority has become the latest enforcer to fine pharmaceutical companies Novartis and Roche for colluding to exaggerate a drug's potential side effects to encourage users to purchase a more expensive one.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.